Esperanza NeuroPeptides ®
 
 
Esperanza Neuropeptide Increase font sizeDecrease font sizePrint pageEmail this page to a friend
Multiple Sclerosis and post stroke treatment

Click here for my testimonial
ataxia (ah-tak'se-ah) - is the failure of muscular coordination; irregularity of muscular action. Ataxia due to loss of proprioception (joint position sensation) between the motor cortex and peripheral nerves, resulting in poorly judged movements, incoordination can become more intense and aggravated when the eyes are closed.
NEWSLETTERS

VOLUME 14 NEWSLETTER 11

EXCITING CHANGES IN ESPERANZA NEUROPEPTIDE PRICING STRUCTURE ALLOWS PATIENTS TO TAKE ADVANTAGE OF A NEW HEAVILY SUBSIDISED 18-MONTH OPTION IN ADDITION TO THE FULL-YEAR (Subsidised) AND NEW HALF-YEAR (Non Subsidised) OPTIONS!

NEW PRICE STRUCTURING COMMENCES JULY 1, 2008

MULTIPLE SCLEROSIS (MS) TREATMENT - Esperanza Peptide offers three treatment prices (a half-year, full-year and 18-month price). First, we offer subsidised, full year and 18-month treatments, that costs the participating patient £5,450 (UK) for full-year and £7,450 for 18-months, $12,500 (USA) for full-year and $17,000 for 18-months, or €7,700 (Europe) for full year, €10,000 for 18-months and equivalent currency in other countries. Second, we offer a 6 month "half-year treatment" for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year or 18-month treatment. The half-year treatment prices are £3,750 (UK), $6,250 (USA) and €5,250 (Europe) this "half-year treatment" unlike the full-year and 18-month treatment price is not subsidised. The costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray. NOTE: there is also a half-year treatment period available. For information and comparison between the full-year treatment and 18-month price and the half-year price click here.

To find out more information about Multiple Sclerosis please see What is MULTIPLE SCLEROSIS (MS)?

ATAXIAS & OLIVOPONTOCEREBELLAR ATROPHY (OPCA) TREATMENT - Esperanza Peptide offers three treatment prices (a half-year, full-year and 18-month price). First, we offer subsidised, full year and 18-month treatment, that costs the participating patient £5,450 (UK) for full-year and £7,450 for 18-months, $12,500 (USA) for full-year and $17,000 for 18-months, or €7,700 (Europe) for full year, €10,000 for 18-months and equivalent currency in other countries. Second, we offer a 6 month "half-year treatment" for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year or 18-month treatment. The half-year treatment prices are £3,750 (UK), $6,250 (USA) and €5,250 (Europe) this "half-year treatment" unlike the full-year and 18-month treatment price is not subsidised. The costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray. NOTE: there is also a half-year treatment period available. For information and comparison between the full-year and 18-month treatment price and the half-year price click here.

To find out more information about Ataxias & Olivopontocerebeller Atrophy please see What is ATAXIAS & OLIVOPONTOCEREBELLAR ATROPHY TREATMENT (OPCA)?

POST STROKE (PS) TREATMENT - Esperanza Peptide offers three treatment prices (a half-year, full-year and 18-month price). First, we offer subsidised, full year and 18-month treatment, that costs the participating patient £5,450 (UK) for full-year and £7,450 for 18-months, $12,500 (USA) for full-year and $17,000 for 18-months, or €7,700 (Europe) for full year, €10,000 for 18-months and equivalent currency in other countries. Second, we offer a 6 month "half-year treatment" for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year or 18-month treatment. The half-year treatment prices are £3,750 (UK), $6,250 (USA) and €5,250 (Europe) this "half-year treatment" unlike the full-year and 18-month treatment price is not subsidised. The costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray. NOTE: there is also a half-year treatment period available. For information and comparison between the full-year and 18-month treatment price and the half-year price click here.

To find out more information about Post Stroke please see What is POST STROKE (PS)?

PRIMARY LATERAL SCLEROSIS (PLS) TREATMENT - Esperanza Peptide offers three treatment prices (a half-year, full-year and 18-month price). First, we offer subsidised, full year and 18-month treatment, that costs the participating patient £5,450 (UK) for full-year and £7,450 for 18-months, $12,500 (USA) for full-year and $17,000 for 18-months, or €7,700 (Europe) for full year, €10,000 for 18-months and equivalent currency in other countries. Second, we offer a 6 month "half-year treatment" for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year or 18-month treatment. The half-year treatment prices are £3,750 (UK), $6,250 (USA) and €5,250 (Europe) this "half-year treatment" unlike the full-year and 18-month treatment price is not subsidised. The costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray. NOTE: there is also a half-year treatment period available. For information and comparison between the full-year and 18-month treatment price and the half-year price click here.

To find out more information about Primary Lateral Sclerosis please see What is PRIMARY LATERAL SCLEROSIS?

LYME DISEASE TREATMENT - LYME DISEASE TREATMENT - Esperanza Peptide offers three treatment prices (a half-year, full-year and 18-month price). First, we offer subsidised, full year and 18-month treatment, that costs the participating patient £5,450 (UK) for full-year and £7,450 for 18-months, $12,500 (USA) for full-year and $17,000 for 18-months, or €7,700 (Europe) for full year, €10,000 for 18-months and equivalent currency in other countries. Second, we offer a 6 month "half-year treatment" for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year or 18-month treatment. The half-year treatment prices are £3,750 (UK), $6,250 (USA) and €5,250 (Europe) this "half-year treatment" unlike the full-year and 18-month treatment price is not subsidised. The costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray. NOTE: there is also a half-year treatment period available. For information and comparison between the full-year and 18-month treatment price and the half-year price click here.

To find out more information about Lyme Disease please see What is LYME DISEASE?

Select another newsletter:  

Subsribe to the Esperanza NeuroPeptide Newsletter

Fields marked like this are required.

If your email account is with Hotmail, AOL or any other provider that blocks newsletter emails, before subscribing please add "esperanzapeptide.net" to your "white List"